pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·55m ago·1 min read
save

Experts unveil four-stage framework for women's heart health across the lifespan

Oct 26, 2026·read at STAT ↗Positive

Experts from the American Heart Association, American Academy of Pediatrics, Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists released a new framework that groups women's heart health into four stages. The aim is to give doctors and patients a clear roadmap from childhood through older age.

The four stages are meant to reflect the unique biological and hormonal changes women experience, helping clinicians identify risk factors and tailor prevention or treatment at each point in life.

The guidance was published in the journal Circulation and builds on research showing that women's heart disease presents differently from men's, from symptoms to underlying causes.

By coordinating care across specialties, the societies hope to lower cardiovascular disease as the top cause of death among women.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The 4 stages of women’s heart health: Experts present new framework”

read at STAT ↗
1,441 words · retrieved 25m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING3UNIQUE3CYCLE2ASTRAZENECADisc Medicine, Inc.JOURNEYNorthwestern University
drugs
iron
topics
Cardiology29Endocrinology & Metabolism4Oncology2Vaccine2HematologyMajor DepressionPsychiatry & CNSType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • 2d agoTango plans 14% workforce cut, mainly of research staffBioSpace
  • Sep 21Behind the outcomes: How whole-patient support is reshaping oncology careBioPharma Dive
  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT